First Header Logo Second Header Logo

Connection

Herbert Bonkovsky to Iron

Back to Details
This is a "connection" page, showing publications Herbert Bonkovsky has written about Iron.
Herbert Bonkovsky
Connection Strength
5.614
Iron
  1. Bossi K, Lee J, Schmeltzer P, Holburton E, Groseclose G, Besur S, Hwang S, Bonkovsky HL. Homeostasis of iron and hepcidin in erythropoietic protoporphyria. Eur J Clin Invest. 2015 Oct; 45(10):1032-41.
    View in: PubMed
    Score: 0.485
  2. Bonkovsky HL. Risk factors for porphyria cutanea tarda -the iron/HFE connection. Liver Int. 2013 Jan; 33(1):162.
    View in: PubMed
    Score: 0.398
  3. Ryan Caballes F, Sendi H, Bonkovsky HL. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int. 2012 Jul; 32(6):880-93.
    View in: PubMed
    Score: 0.383
  4. Hwang SI, Lee YY, Park JO, Norton HJ, Clemens E, Schrum LW, Bonkovsky HL. Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method. Clin Chim Acta. 2011 Nov 20; 412(23-24):2241-7.
    View in: PubMed
    Score: 0.366
  5. Hou WH, Rossi L, Shan Y, Zheng JY, Lambrecht RW, Bonkovsky HL. Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. World J Gastroenterol. 2009 Sep 28; 15(36):4499-510.
    View in: PubMed
    Score: 0.321
  6. Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology. 2006 Nov; 131(5):1440-51.
    View in: PubMed
    Score: 0.259
  7. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis. 2005 Nov; 25(4):461-72.
    View in: PubMed
    Score: 0.245
  8. Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis. 2005 Mar 15; 40(6):834-41.
    View in: PubMed
    Score: 0.234
  9. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003 Jun; 30(2):137-44.
    View in: PubMed
    Score: 0.207
  10. Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q, Hsieh CC. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol. 2002 Dec; 37(6):848-54.
    View in: PubMed
    Score: 0.200
  11. Bonkovsky HL, Davidoff A, Stark DD. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000 Nov 30; 343(22):1656; author reply 1657.
    View in: PubMed
    Score: 0.174
  12. Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology. 2000 Mar; 31(3):730-6.
    View in: PubMed
    Score: 0.165
  13. Salaye L, Bychkova I, Sink S, Kovalic AJ, Bharadwaj MS, Lorenzo F, Jain S, Harrison AV, Davis AT, Turnbull K, Meegalla NT, Lee SH, Cooksey R, Donati GL, Kavanagh K, Bonkovsky HL, McClain DA. A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. Nutrients. 2019 Sep 10; 11(9).
    View in: PubMed
    Score: 0.160
  14. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol. 1999 Sep; 31(3):421-9.
    View in: PubMed
    Score: 0.160
  15. Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology. 1999 Jul; 212(1):227-34.
    View in: PubMed
    Score: 0.158
  16. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology. 1997 Mar; 25(3):759-68.
    View in: PubMed
    Score: 0.134
  17. Bonkovsky HL, Ponka P, Bacon BR, Drysdale J, Grace ND, Tavill AS. An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism. Hepatology. 1996 Sep; 24(3):718-29.
    View in: PubMed
    Score: 0.130
  18. Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol. 2016 Aug 07; 22(29):6742-56.
    View in: PubMed
    Score: 0.129
  19. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis. 1996 Feb; 16(1):65-82.
    View in: PubMed
    Score: 0.125
  20. Rubin RB, Barton AL, Banner BF, Bonkovsky HL. Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis. 1995 Jul-Aug; 13(4):223-38.
    View in: PubMed
    Score: 0.120
  21. Barton AL, Banner BF, Cable EE, Bonkovsky HL. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol. 1995 Apr; 103(4):419-24.
    View in: PubMed
    Score: 0.118
  22. Cable EE, Healey JF, Greene Y, Evans CO, Bonkovsky HL. Synergistic induction of delta-aminolevulinate synthase by glutethimide and iron: relationship to the synergistic induction of heme oxygenase. Biochim Biophys Acta. 1991 Nov 15; 1080(3):245-51.
    View in: PubMed
    Score: 0.093
  23. Lambrecht RW, Sterling RK, Naishadham D, Stoddard AM, Rogers T, Morishima C, Morgan TR, Bonkovsky HL. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011 May; 140(5):1490-500.e3.
    View in: PubMed
    Score: 0.088
  24. Bonkovsky HL. Iron and the liver. Am J Med Sci. 1991 Jan; 301(1):32-43.
    View in: PubMed
    Score: 0.088
  25. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology. 1990 Oct; 99(4):1079-91.
    View in: PubMed
    Score: 0.086
  26. Bonkovsky HL, Weber R, Aaron L. Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion. Am J Gastroenterol. 1990 May; 85(5):554-7.
    View in: PubMed
    Score: 0.084
  27. Bacon BR, Healey JF, Brittenham GM, Park CH, Nunnari J, Tavill AS, Bonkovsky HL. Hepatic microsomal function in rats with chronic dietary iron overload. Gastroenterology. 1986 Jun; 90(6):1844-53.
    View in: PubMed
    Score: 0.064
  28. Agrawal S, Bonkovsky HL. Management of nonalcoholic steatohepatitis: an analytic review. J Clin Gastroenterol. 2002 Sep; 35(3):253-61.
    View in: PubMed
    Score: 0.049
  29. Rolfs A, Bonkovsky HL, Kohlroser JG, McNeal K, Sharma A, Berger UV, Hediger MA. Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Apr; 282(4):G598-607.
    View in: PubMed
    Score: 0.048
  30. Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002 Jan; 97(1):1-4.
    View in: PubMed
    Score: 0.047
  31. Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, Killenberg P, Hunt C, Tamburro C, Tavill AS, Ferguson R, Krawitt E, Banner B, Bacon BR. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology. 2000 Jul; 32(1):135-8.
    View in: PubMed
    Score: 0.042
  32. Bonkovsky HL, Lambrecht RW. Iron-induced liver injury. Clin Liver Dis. 2000 May; 4(2):409-29, vi-vii.
    View in: PubMed
    Score: 0.042
  33. Kowdley KV, Trainer TD, Saltzman JR, Pedrosa M, Krawitt EL, Knox TA, Susskind K, Pratt D, Bonkovsky HL, Grace ND, Kaplan MM. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology. 1997 Oct; 113(4):1270-7.
    View in: PubMed
    Score: 0.035
  34. Bonkovsky HL. Therapy of hepatitis C: other options. Hepatology. 1997 Sep; 26(3 Suppl 1):143S-151S.
    View in: PubMed
    Score: 0.035
  35. Banner BF, Barton AL, Cable EE, Smith L, Bonkovsky HL. A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod Pathol. 1995 Apr; 8(3):232-8.
    View in: PubMed
    Score: 0.029
  36. Lambrecht RW, Cable JW, Pepe JA, Bonkovsky HL. 3,5,5-Trimethylhexanoylferrocene induction of heme oxygenase activity in normal hepatocytes. Biochem Pharmacol. 1994 Apr 29; 47(9):1669-76.
    View in: PubMed
    Score: 0.028
  37. Cable EE, Cable JW, Bonkovsky HL. Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: relationship to inhibition of heme oxygenase. Hepatology. 1993 Jul; 18(1):119-27.
    View in: PubMed
    Score: 0.026
  38. Greene YJ, Healey JF, Bonkovsky HL. Immunochemical studies of haem oxygenase. Preparation and characterization of antibodies to chick liver haem oxygenase and their use in detecting and quantifying amounts of haem oxygenase protein. Biochem J. 1991 Nov 01; 279 ( Pt 3):849-54.
    View in: PubMed
    Score: 0.023
  39. Cable E, Greene Y, Healey J, Evans CO, Bonkovsky H. Mechanism of synergistic induction of hepatic heme oxygenase by glutethimide and iron: studies in cultured chick embryo liver cells. Biochem Biophys Res Commun. 1990 Apr 16; 168(1):176-81.
    View in: PubMed
    Score: 0.021
  40. Bonkovsky HL, Mitchell WJ, Healey JF. Effect of hemochromatosis on hepatic cytochrome P450 and antipyrine metabolism in humans. Clin Chem. 1984 Aug; 30(8):1430-1.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.